VTVT
vTv Therapeutics Inc.
$34.12
-0.42 (-1.22%)
At close · Jul 7
Market Cap
$135.52M
Shares
3,938,895
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$0
-100%
FY2025
Net Income
-$26.97M
-46.1%
FY2025
Operating Margin
-2377.58%
FY2024
Operating Cash Flow
-$25.26M
+0.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $36.84M | $0 | $1.02M | $0 | $2.02M | $4.01M | $6.41M | $2.76M | $12.43M | $291K | $634K | $519K | $1.55M | $976K | |
| $24.01M | $17.86M | $11.55M | $13.6M | $12.36M | $13.32M | $11.02M | $15.12M | $23.04M | $39.64M | $44.95M | $27.24M | $17.38M | $22.29M | |
| $15.87M | $14.95M | $13.65M | $11.91M | $12.2M | $12.34M | $7.25M | $8.54M | $9.22M | $11.33M | $9.91M | $9.08M | $11.72M | $11.38M | |
| $39.88M | $32.81M | $25.2M | $25.5M | $24.56M | $25.67M | $18.27M | $23.66M | $32.26M | $50.97M | $55.65M | $38.66M | $30.45M | $36.81M | |
| -$3.04M | -$32.81M | -$24.18M | -$25.5M | -$22.54M | -$21.66M | -$11.85M | -$20.89M | -$19.82M | -$50.68M | -$55.02M | -$38.14M | -$28.9M | -$35.83M | |
| — | — | -2377.58% | — | -1116.95% | -540.87% | -184.78% | -755.86% | -159.43% | -17416.49% | -8678.23% | -7349.13% | -1865.53% | -3671.41% | |
| — | — | $0 | $13K | $15K | $12K | $692K | $1.83M | $3.29M | $3.09M | $398K | $108K | $286K | $476K | |
| $2.38M | $1.87M | $1.57M | $472K | $352K | $1000 | $12K | $53K | $61K | $117K | $87K | $40K | $4000 | — | |
| — | — | — | -$1.5M | -$3.62M | $2.45M | $0 | $1000 | $46K | — | -$22K | -$838K | -$503K | $41K | |
| -$729K | -$31.08M | -$22.61M | -$25.97M | -$24.87M | -$17.62M | -$12.8M | -$21.84M | -$23.65M | -$53.85M | -$55.35M | -$41.11M | -$36.1M | -$48.2M | |
| $0 | $0 | $100K | $0 | $200K | $115K | $0 | $100K | $200K | $800K | $0 | $0 | $0 | — | |
| $2.25M | -$26.97M | -$18.46M | -$20.25M | -$19.16M | -$12.99M | -$8.5M | -$13.04M | -$7.91M | -$16.14M | -$16.35M | -$27.5M | -$36.1M | -$48.2M | |
| — | — | -1815.34% | — | -949.65% | -324.27% | -132.51% | -471.92% | -63.62% | -5547.77% | -2579.18% | -5298.27% | -2330.6% | -4938.83% | |
| -$2.98M | -$4.11M | -$4.24M | -$5.72M | -$5.91M | -$4.74M | -$4.3M | -$8.89M | -$15.93M | -$38.5M | -$39M | -$13.61M | — | — | |
| $2.25M | -$26.97M | -$18.46M | -$20.25M | -$19.16M | -$12.99M | -$8.5M | -$17.91M | -$8.65M | -$16.14M | -$16.35M | — | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2024-12-31 | 2022-12-31 |
|---|---|---|
| Reportable Segment | $1,000,000 | $2,000,000 |